Kinetic studies of the reactivity between cisplatin and its monoaquo species with L-methioniae

被引:45
作者
Heudi, O [1 ]
Cailleux, A [1 ]
Allain, P [1 ]
机构
[1] CHU Angers, Lab Pharmacol & Toxicol, F-49033 Angers 01, France
关键词
cisplatin; cisplatin aquated species; L-methionine; methionine-platinum adducts; HPLC-ICPMS/LC-MS;
D O I
10.1016/S0162-0134(98)10033-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin readily undergoes reaction with L-met but little is known about the mechanism of their interactions. This paper deals with the study of the reaction of L-met with various solutions of cisplatin: fresh aqueous [CP](1), saline [CP](2) and aquated [AP] which predominantly contained the monoaquo species. The initial rate of decrease of L-met concentration measured by HPLC-W after its incubation at 1:1 mole ratio with [CP](1), [CP](2) and [AP] was 0.1 mM h(-1) +/- 0.02, 0.24 mM h(-1) +/- 0.007 and 0.5 mM h(-1) +/- 0.04, respectively. Reactions of L-met with [CP](1), [CP](2) and [AP] after 24 h of incubation lead to the formation of the same met-platinum adducts M1, M2, M3, M4 and M5 detected by ICPMS. The structure of M2, M4 and M5 which were characterized by LC-MS are in good agreement with those described by other investigators using different methods while, M1 whose structure corresponded to cis-{Pt[(NH3)(2)(met)Cl]} was already postulated but never characterized so far. The rate of hydrolysis of cisplatin into monoaquo species was evaluated to be 0.06 h(-1) +/- 0.006. In addition, the monoaquo species reacted more rapidly with L-met than cisplatin to yield M1. The latter species then underwent parallel reaction to give M2 which reacted with L-met to give M5 via the formation of M3. This study shows the higher reactivity with L-met of the monoaquo species relative to cisplatin and the usefulness of the combination of HPLC-UV-ICPMS and LC-MS for the characterization of platinum aminoacid adducts. (C) 1998 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:61 / 69
页数:9
相关论文
共 32 条
[11]   CISPLATIN METABOLITES IN PLASMA, A STUDY OF THEIR PHARMACOKINETICS AND IMPORTANCE IN THE NEPHROTOXIC AND ANTITUMOUR ACTIVITY OF CISPLATIN [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (19) :3063-3070
[12]   THE INHIBITION OF RENAL ATPASE BY CISPLATIN AND SOME BIOTRANSFORMATION PRODUCTS [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
CHEMICO-BIOLOGICAL INTERACTIONS, 1982, 40 (03) :325-334
[13]   CISPLATIN METABOLITES - A METHOD FOR THEIR SEPARATION AND FOR MEASUREMENT OF THEIR RENAL CLEARANCE INVIVO [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (01) :181-184
[14]   ANALYSIS OF PLATINUM SPECIES ORIGINATING FROM CIS-DIAMMINEDICHLOROPLATINUM(II) (CISPLATIN) IN HUMAN AND RAT PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROMETRIC DETECTION [J].
DEWAAL, WAJ ;
MAESSEN, FJMJ ;
KRAAK, JC .
JOURNAL OF CHROMATOGRAPHY, 1987, 407 :253-272
[15]  
GAMELIN E, 1995, CANCER CHEMOTH PHARM, V37, P97
[16]   STABILITY OF CISPLATIN IN AQUEOUS-SOLUTION [J].
GREENE, RF ;
CHATTERJI, DC ;
HIRANAKA, PK ;
GALLELLI, JF .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01) :38-43
[17]   Interactions between cisplatin derivatives and mobile phase during chromatographic separation [J].
Heudi, O ;
Cailleux, A ;
Allain, P .
CHROMATOGRAPHIA, 1997, 44 (1-2) :19-24
[18]   PLATINUM ANTITUMOR AGENTS - A REVIEW OF (BIO)ANALYSIS [J].
HODES, TJM ;
UNDERBERG, WJM ;
LOS, G ;
BEIJNEN, JH .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1992, 14 (03) :61-77
[19]   CIS-DICHLORODIAMMINEPLATINUM(II) - AQUATION EQUILIBRIA AND ISOTOPIC-EXCHANGE OF CHLORIDE LIGANDS WITH FREE CHLORIDE AND TETRACHLOROPLATINATE(II) [J].
LEE, KW ;
MARTIN, DS .
INORGANICA CHIMICA ACTA, 1976, 17 (01) :105-110
[20]   THE HYDROLYSIS PRODUCTS OF CIS-DIAMMINEDICHLOROPLATINUM(II) .5. THE ANATION KINETICS OF CIS-PT(X)(NH3)2(OH2)+ (X = CL, OH) WITH GLYCINE, MONOHYDROGEN MALONATE AND CHLORIDE [J].
MILLER, SE ;
HOUSE, DA .
INORGANICA CHIMICA ACTA, 1991, 187 (02) :125-132